Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group
Abstract
Twenty-one consecutive patients with streptococcal toxic shock syndrome (TSS) between December 1994 and April 1995 were treated with a median dose of 2 g of intravenous immunoglobulin (IVIG)/kg (cases) and were compared with 32 patients with streptococcal TSS between 1992 and 1995 who did not receiv …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
non-u.s. gov't
u.s. gov't
non-p.h.s.
female
male
middle aged
Comparative Study
P.H.S.
immunoglobulins
intravenous / therapeutic use*
case-control studies
neutralization tests
streptococcal infections / microbiology
analysis of variance
shock
streptococcal infections / drug therapy*
septic / microbiology
pmid:10825042
doi:10.1086/515199
r kaul
a mcgeer
d e low
apache
mitogens / physiology
septic / drug therapy*
streptococcus pyogenes* / immunology
Access
Citation
ID:
117087
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
117087
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
